WHAT'S GOING ON WITH BIOSIMILARS?

The article offers developments related to biosimilars and the biologic industry in the U.S., adapted from Chapter 9 of the "2016 Supplement to Pharmaceutical and Medical Device Law." The topics discussed include the attributes of biosimilar products, the approval given by the federal agency the U.S. Food and Drugs Administration (FDA) on biosimilar products from pharmaceutical companies like Janssen Biotech Inc. and Sandoz AG, and the guidance issued by the FDA for biosimilar products.